| Visceral leishmaniasis: what are the needs for diagnosis, treatment and control? F Chappuis, S Sundar, A Hailu, H Ghalib, S Rijal, RW Peeling, J Alvar, ... Nature reviews microbiology 5 (11), 873-882, 2007 | 2089 | 2007 |
| Whole genome sequencing of multiple Leishmania donovani clinical isolates provides insights into population structure and mechanisms of drug resistance T Downing, H Imamura, S Decuypere, TG Clark, GH Coombs, JA Cotton, ... Genome research 21 (12), 2143-2156, 2011 | 487 | 2011 |
| Increasing failure of miltefosine in the treatment of Kala-azar in Nepal and the potential role of parasite drug resistance, reinfection, or noncompliance S Rijal, B Ostyn, S Uranw, K Rai, NR Bhattarai, TPC Dorlo, JH Beijnen, ... Clinical Infectious Diseases 56 (11), 1530-1538, 2013 | 356 | 2013 |
| A meta-analysis of the diagnostic performance of the direct agglutination test and rK39 dipstick for visceral leishmaniasis F Chappuis, S Rijal, A Soto, J Menten, M Boelaert Bmj 333 (7571), 723, 2006 | 356 | 2006 |
| Diagnostic tests for kala-azar: a multi-centre study of the freeze-dried DAT, rK39 strip test and KAtex in East Africa and the Indian subcontinent M Boelaert, S El-Safi, A Hailu, M Mukhtar, S Rijal, S Sundar, M Wasunna, ... Transactions of the Royal Society of Tropical Medicine and Hygiene 102 (1 …, 2008 | 228 | 2008 |
| A comparative study of the effectiveness of diagnostic tests for visceral leishmaniasis M Boelaert, S Rijal, S Regmi, R Singh, B Karki, D Jacquet, F Chappuis, ... American Journal of Tropical Medicine and Hygiene 70 (1), 72, 2004 | 215 | 2004 |
| Rapid tests for the diagnosis of visceral leishmaniasis in patients with suspected disease M Boelaert, K Verdonck, J Menten, T Sunyoto, J van Griensven, ... Cochrane database of systematic reviews, 2014 | 205 | 2014 |
| Visceral leishmaniasis in the Indian subcontinent: modelling epidemiology and control A Stauch, RR Sarkar, A Picado, B Ostyn, S Sundar, S Rijal, M Boelaert, ... PLoS neglected tropical diseases 5 (11), e1405, 2011 | 202 | 2011 |
| Eliminating the neglected tropical diseases: translational science and new technologies PJ Hotez, B Pecoul, S Rijal, C Boehme, S Aksoy, M Malecela, ... PLoS neglected tropical diseases 10 (3), e0003895, 2016 | 197 | 2016 |
| Recent development of visceral leishmaniasis treatments: successes, pitfalls, and perspectives F Alves, G Bilbe, S Blesson, V Goyal, S Monnerat, C Mowbray, ... Clinical microbiology reviews 31 (4), 10.1128/cmr. 00048-18, 2018 | 192 | 2018 |
| A global comparative evaluation of commercial immunochromatographic rapid diagnostic tests for visceral leishmaniasis J Cunningham, E Hasker, P Das, S El Safi, H Goto, D Mondal, M Mbuchi, ... Clinical infectious diseases 55 (10), 1312-1319, 2012 | 182 | 2012 |
| Incidence of Symptomatic and Asymptomatic Leishmania donovani Infections in High-Endemic Foci in India and Nepal: A Prospective Study B Ostyn, K Gidwani, B Khanal, A Picado, F Chappuis, SP Singh, S Rijal, ... PLoS Neglected Tropical Diseases 5 (10), e1284, 2011 | 178 | 2011 |
| Gene Expression Analysis of the Mechanism of Natural Sb(V) Resistance in Leishmania donovani Isolates from Nepal S Decuypere, S Rijal, V Yardley, S De Doncker, T Laurent, B Khanal, ... Antimicrobial agents and chemotherapy 49 (11), 4616-4621, 2005 | 176 | 2005 |
| The sensitivity of clinical isolates of Leishmania from Peru and Nepal to miltefosine. V Yardley, SL Croft, S De Doncker, JC Dujardin, S Koirala, S Rijal, ... The American journal of tropical medicine and hygiene 73 (2), 272-275, 2005 | 175 | 2005 |
| Evolutionary genomics of epidemic visceral leishmaniasis in the Indian subcontinent H Imamura, T Downing, F Van den Broeck, MJ Sanders, S Rijal, S Sundar, ... Elife 5, e12613, 2016 | 162 | 2016 |
| Failure of miltefosine in visceral leishmaniasis is associated with low drug exposure TPC Dorlo, S Rijal, B Ostyn, PJ de Vries, R Singh, N Bhattarai, S Uranw, ... The Journal of infectious diseases 210 (1), 146-153, 2014 | 155 | 2014 |
| Evaluation of rapid diagnostic tests: visceral leishmaniasis M Boelaert, S Bhattacharya, F Chappuis, SH El Safi, A Hailu, D Mondal, ... Nature Reviews Microbiology 5 (Suppl 11), S31-S39, 2007 | 151 | 2007 |
| Treatment of visceral leishmaniasis in south-eastern Nepal: decreasing efficacy of sodium stibogluconate and need for a policy to limit further decline S Rijal, F Chappuis, R Singh, PA Bovier, P Acharya, BMS Karki, ML Das, ... Transactions of the Royal Society of Tropical Medicine and Hygiene 97 (3 …, 2003 | 150 | 2003 |
| Visceral leishmaniasis: elimination with existing interventions G Matlashewski, B Arana, A Kroeger, S Battacharya, S Sundar, P Das, ... The Lancet infectious diseases 11 (4), 322-325, 2011 | 147 | 2011 |
| Cost-effectiveness analysis of combination therapies for visceral leishmaniasis in the Indian subcontinent F Meheus, M Balasegaram, P Olliaro, S Sundar, S Rijal, MA Faiz, ... PLoS Neglected Tropical Diseases 4 (9), e818, 2010 | 136 | 2010 |
